Medi-Ject trims near-term revenue estimate: Medi-Ject Corp said it had lowered its near-term revenue expectations after Schering-Plough Corp decided not to place orders for Medi-Ject's needle-free drug delivery system. Medi-Ject announced on March 19 that it had signed an exclusive worldwidelicensing and supply agreement to provide pharmaceutical company Schering-Plough with a needle-free injection system for a drug used to treat hepatitis and cancer.

TCSI Corp warns of Q3 EPS shortfall: Telecommunications software provider TCSI Corp has warned that the company expects to report a third quarter per share loss of $0.07 to $0.09. The First Call consensus forecast had predicted a $0.01 per share profit after a $0.02 loss a year earlier. It did not provide a reason for the shortfall in the statement it released.

"This quarter's results are disappointing, particularly in light of the steady progress we have experienced over the past several quarters," Ram Banin, company president, said in the statement. "Our balance sheet continues to be strong and we firmly believe that our component-based strategy offers the right solution for the global telecom market," he added. Third-quarter revenues will total about $9 million, the company noted.

Scotsman sees Q3 EPS at $0.56: ScotsmanIndustries Inc., a manufacturer of commercial refrigeration products, said Friday it expects to post third quarter earnings of about $0.56 a diluted share as reported last year, below analysts' estimates ranging from $0.69 to $0.72 a share.

Third-quarter sales are expected to be up moderately compared to last year, the company said, with gains in all product lines except food preparation and storage equipment. For the third quarter of 1997, Scotsman reported sales of $159.68 million.